What one share of Lensar holds
We are a commercial-stage medical device company focused on designing, developing and marketing advanced laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.
Lensar’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.35 |
|---|---|
| Profit | $0.82 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.41 |
| Cash and investments | $1.10 |
| Debt | $0.31 |
| Book value | $1.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $28.53 | −$13.70 | $0.36 | −$12.13 | — | −$28.55 |
| 2020 | $5.71 | −$4.28 | $0.08 | −$3.06 | — | — |
| 2021 | $3.68 | −$2.09 | $0.04 | −$0.99 | — | $4.99 |
| 2022 | $3.48 | −$1.96 | $0.01 | −$1.47 | — | $3.78 |
| 2023 | $3.84 | −$1.31 | $0.02 | −$0.90 | — | $2.95 |
| 2024 | $4.64 | −$2.73 | $0.01 | −$0.21 | — | $0.42 |
| 2025 | $4.89 | −$2.87 | $0.01 | −$1.25 | — | −$2.17 |
Common questions about Lensar
How much does one share of Lensar earn?
Over the last 12 months, each share of Lensar earned $0.82 of profit on $3.35 of sales, keeping about 24¢ of every $1 (profit margin).
Does Lensar pay a dividend?
Lensar didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Lensar’s book value per share?
Lensar’s book value is $1.21 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Lensar have?
Each share of Lensar has $1.10 of cash and investments and $0.31 of debt, as of June 30, 2026.
What is Lensar’s free cash flow per share?
−$0.41 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Lensar bought back shares?
Lensar’s share count rose about 1018% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.